Butylphthalide intravenous emulsion and application thereof

Details for Australian Patent Application No. 2006324219 (hide)

International Classifications

Event Publications

24 July 2008 PCT application entered the National Phase

PCT publication WO2007/068212 Priority application(s): WO2007/068212

18 September 2008 Amendment Made

The nature of the amendment is: Amend the invention title to read Butylphthalide intravenous emulsion and application thereof 2006326257 Novartis AG The nature of the amendment is: Amend the invention title to read (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders 2007

4 March 2010 Application Accepted

Published as AU-B-2006324219

27 May 2010 Alteration of Name

The name of the applicant has been altered to CSPC NBP Pharmaceutical Co. Ltd.

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.